Evidence map›Paper›PMID 38814265›Full record

ArticleBiomacromolecules2024

Isoprenoid CARTs:

Harrison P Rahn, Jiuzhi Sun, Zhijian Li, Robert M Waymouth, Ronald Levy, Paul A Wender

Abstract read
In one paragraph

Article in Biomacromolecules, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Harrison P RahnDepartment of Chemistry, Stanford University, Stanford, California 94305, United States.ORCID 0000-0001-5086-6935
Jiuzhi SunDepartment of Chemistry, Stanford University, Stanford, California 94305, United States.
Zhijian LiDepartment of Chemistry, Stanford University, Stanford, California 94305, United States.ORCID 0000-0003-1849-1672
Robert M WaymouthDepartment of Chemistry, Stanford University, Stanford, California 94305, United States.ORCID 0000-0001-9862-9509
Ronald LevyStanford Cancer Institute, Division of Oncology, Department of Medicine, Stanford University, Stanford, California 94305, United States.
Paul A WenderDepartment of Chemistry, Stanford University, Stanford, California 94305, United States.ORCID 0000-0001-6319-2829

Funding

SYNTHETIC STUDIES RELATED TO CANCER RESEARCH/TREATMENTR01CA031845 · NCI · STANFORD UNIVERSITY · PI PAUL Anthony WENDER · 1985 to 2026
$6.9M
Natural killer cell engineering to target the HIV reservoirR01AI161803 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BLISH, CATHERINE A, ZACK, JEROME A. · 2021 to 2025
$3.8M
New Materials to Deliver mRNA: Applications in Cancer ImmunotherapyR01CA245533 · NCI · STANFORD UNIVERSITY · PI LEVY, RONALD, WAYMOUTH, ROBERT M. · 2020 to 2024
$2.6M
NCI NIH HHS R01 CA031845NCI NIH HHS R01 CA245533NIAID NIH HHS R01 AI161803
6 · The paper itself

Abstract

The delivery of oligonucleotides across biological barriers is a challenge of unsurpassed significance at the interface of materials science and medicine, with emerging clinical utility in prophylactic and therapeutic vaccinations, immunotherapies, genome editing, and cell rejuvenation. Here, we address the role of readily available branched lipids in the design, synthesis, and evaluation of isoprenoid charge-altering releasable transporters (CARTs), a pH-responsive oligomeric nanoparticle delivery system for RNA. Systematic variation of the lipid block reveals an emergent relationship between the lipid block and the neutralization kinetics of the polycationic block. Unexpectedly, iA21A11, a CART with the smallest lipid side chain, isoamyl-, was identified as the lead isoprenoid CART for the

Indexed as

LipidsRNA, MessengerAnimalsArchaeaHumansMiceNanoparticlesTerpenesLipidsRNA, MessengerTerpenes

Identifiers

PMID38814265
PMCPMC12410861

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.